Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • SEPTEMBER 2021 Issue has been successfully launched on 1 September 2021.



Amit Vaibhav*, O. P. Singh and S. K. Tiwari


Background: In recent years there is alarming increase in the incidence of Diabetes Mellitus globally. The present antidiabetic medicines are satisfactory due to its ill effect on body and drug resistance, So modern researchers and scientists work more in the field of alternative medicines specially ayurvedic preparations, which is safe and also prevent late complication of Diabetes without causing resistance. Aim: The main aim of the present work to evaluate the Antidiabetic effect of some indigenous herbal compound drugs in randomly selected 78 Madhumeha (NIDDM) patients on the ground of subjective parameter. Study Design: All the registered subjects have been divided into three groups, 26 patients in each group. In group A (Indigenous compound drugs- DIMIT Ghan Vati) 26 patients, Group B (Glimipride) 23 and in Group-3 (DIMIT Ghan Vati+ Glimipride) 20 patients completed all the three follow ups (15days) in the total duration of 45 days of study. Assessment parameters include Symptometic grading scale with 0,1,2 and 3 grade assessed after each follow up. Discussion: Statistical analysis showed significant improvement in subjective parameters of Madhumeha (NIDDM) patients in all three the groups. Conclusion : Diabetic Patients with mild symptoms responded well with trial drug and its action is comparable to Glimipride (OHA).

Keywords: Madhumeha, NIDDM, DIMIT ghan vati, Glimipride.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More